Stay updated on TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial
Sign up to get notified when there's something new on the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page.

Latest updates to the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Locations section lists study sites in Arizona, Colorado, Florida, Georgia, New York, North Carolina, Ohio, Pennsylvania, and Virginia. The previous per-state location headings were removed and the revision updated to v3.3.3.SummaryDifference1.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. No substantive changes to study details, eligibility criteria, locations, or outcomes are visible.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page no longer displays the government funding lapse notice, which is a site-wide operational message and not part of the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedMinor layout and styling adjustments to the Study Details page with no changes to core study information such as eligibility criteria, interventions, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedSummary: The page adds a government-operating-status notice and new version v3.2.0, replacing v3.1.0. The deletions remove the previous v3.1.0 tag.SummaryDifference3%

- Check99 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several topics (Drug Safety, Counterfeit Drugs, Substandard Drugs) associated with MedlinePlus, plus an older Revision: v3.0.2.SummaryDifference0.4%

Stay in the know with updates to TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page.